SCYNEXIS, Inc. (LON:0L49)
0.6256
-0.0045 (-0.71%)
At close: Dec 19, 2025
SCYNEXIS Revenue
SCYNEXIS had revenue of $334.00K USD in the quarter ending September 30, 2025, a decrease of -49.39%. This brings the company's revenue in the last twelve months to $2.93M, down -65.53% year-over-year. In the year 2024, SCYNEXIS had annual revenue of $3.75M, down -97.33%.
Revenue (ttm)
$2.93M
Revenue Growth
-65.53%
P/S Ratio
9.02
Revenue / Employee
$104.71K
Employees
28
Market Cap
19.67M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.75M | -136.40M | -97.33% |
| Dec 31, 2023 | 140.14M | 135.05M | 2,652.72% |
| Dec 31, 2022 | 5.09M | -8.07M | -61.32% |
| Dec 31, 2021 | 13.16M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | 121.00K | -136.00K | -52.92% |
| Dec 31, 2018 | 257.00K | - | - |
| Dec 31, 2017 | 257.00K | - | - |
| Dec 31, 2016 | 257.00K | - | - |
| Dec 31, 2015 | 257.00K | -999.00K | -79.54% |
| Dec 31, 2014 | 1.26M | -8.31M | -86.87% |
| Dec 31, 2013 | 9.57M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |